Mast cells in autoinflammatory diseases
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at whether mast cells, a type of immune cell, play a role in autoinflammatory diseases. It compares blood samples from patients with these diseases, healthy people, and people with mastocytosis to find new clues for better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18 years.
- You have an autoinflammatory disease and are already followed at a specific French reference center (CeRéMAIA) or you are a healthy volunteer or have mastocytosis.
- You are enrolled in the JIRcohorte (a French patient registry) if you have an autoinflammatory disease.
- You are covered by French social security.
- You can speak and understand French.
- You are able to answer questions and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood “biomarkers,” or measurable body signals, in people with autoimmune diseases, vasculitis, or autoinflammatory conditions. The goal is to better understand these illnesses and how they relate to disease activity.
This study looks for genetic causes of hard-to-diagnose autoinflammatory diseases or a related condition called AA amyloidosis. It aims to find answers for people whose condition does not fit any known type, by studying their genes and medical history.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.
This study looks at blood samples to better understand inflammation pathways in people with rare autoinflammatory diseases. It may help develop better tests and treatments for these conditions.
This study looks at the gut bacteria (microbiome) in people with autoinflammatory diseases. It may help researchers understand how bacteria in the gut affect inflammation and find better ways to treat these conditions.
Hear when a new Autoinflammatory Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.